Swedish Orphan Biovitrum

Tweet this page
<
2013
2014
2015
2016
2017
>
No longer registered as of 04 Jun 2018 - Registration as it was on 22 May 2017
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 232923831740-31

Overview

Lobbying Costs

37,500€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Swedish Orphan Biovitrum   (Sobi)

    EU Transparency Register

    050036210658-03 First registered on 21 Feb 2013

    Goals / Remit

    Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on inflammation and rare genetic diseases. Sobi also markets a portfolio of specialty and rare disease products for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing.

    Main EU files targeted

    Orphan Medicinal Products, rare disease policies, pricing & reimbursement, Health Technology Assessment

    Address

    Head Office
    Tomtebodevägen, 23A
    Solna
    Stockholm SE-11276
    SWEDEN
    EU Office
    Rue Neerveld, 101-103
    Brussels B-1200
    BELGIUM
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 18 May 2024

    Name Start date End Date
    Ms Emma Eatwell 22 Oct 2013 19 Oct 2014
    Ms Sarah Khor 18 Oct 2013 17 Oct 2014

    Complementary Information

    This number takes into account a sum of percentage of time of direct employees plus support from external consultants.

    Person in charge of EU relations

    Ms Ana Palma (Global Patient Access)

    Person with legal responsibility

    Mr Guido Oelkers (Chief Executive Officer)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    At European level, Sobi is an active participant in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and a member company of the European Association for BioIndustries (EuropaBio). At national level, Sobi is a member of several local representative bodies. These are listed on www.sobi.com or are available upon request.

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    37,500€

    Other financial info

    This number takes into account percentage of time / costs related to direct employees' activities in this regard, plus support from external consultants.

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    Participation in European Commission-led and other EU-level policy activities in the field of rare diseases and the research, development and availability of Orphan Medicinal Products.

  • Meetings

    Meetings

    None declared

Download this datacard